Expression of key enzymes of purine and pyrimidine metabolism in a hepatocyte-derived cell line at different phases of the growth cycle
- PMID: 2370250
- PMCID: PMC12200564
- DOI: 10.1007/BF01612899
Expression of key enzymes of purine and pyrimidine metabolism in a hepatocyte-derived cell line at different phases of the growth cycle
Abstract
The effect of growth phase on enzymatic activities of the de novo and salvage pathways for purine and pyrimidine nucleotide synthesis was studied in a hepatocyte-derived cell line from the rat. The cells were in lag phase after plating for 36 h; log phase started at 48 h and persisted up to 120 h of culture. Then the cells stopped growing and entered into plateau phase (144 h). In non-proliferating cells (144 h of culture) the basal activities of the enzymes of purine de novo biosynthesis were 1.7- to 6.8-fold higher than in normal rat liver, those of pyrimidine de novo synthesis showed 0.6- to 30-fold increase in activity. The purine salvage enzymes were unchanged, and the pyrimidine salvage enzymes were 3.1- to 7.4-fold higher compared to normal liver. During the growth cycle all enzymes except the purine salvage enzymes, which did not change, showed a peak in activity at 72 h of culture (log phase). The increase in activity in log phase compared to plateau phase was 1.3- to 2.4-fold for purine de novo synthetic enzymes, 1.1- to 2.4-fold for pyrimidine de novo enzymes, and 1.4- to 4.7-fold for pyrimidine salvage enzymes. The specific activities of the enzymes in exponentially growing cells were comparable either to that in 24-h regenerating liver, or to that in hepatomas of low or medium growth rate. It was concluded that the enzymatic pattern and metabolic state of the cells shared some features with regenerating liver, others with tumors, although they were not tumorigenic after transplantation into athymic nude mice.
Similar articles
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD010533. doi: 10.1002/14651858.CD010533.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2025 Mar 26;3:CD010533. doi: 10.1002/14651858.CD010533.pub3. PMID: 25572491 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.Neoplasia. 2018 Sep;20(9):894-904. doi: 10.1016/j.neo.2018.07.006. Epub 2018 Aug 15. Neoplasia. 2018. PMID: 30121007 Free PMC article.
-
Purine biosynthetic enzymes assemble into liquid-like condensates dependent on the activity of chaperone protein HSP90.J Biol Chem. 2022 May;298(5):101845. doi: 10.1016/j.jbc.2022.101845. Epub 2022 Mar 18. J Biol Chem. 2022. PMID: 35307352 Free PMC article.
-
Role of HSP90 in the Regulation of de Novo Purine Biosynthesis.Biochemistry. 2018 Jun 12;57(23):3217-3221. doi: 10.1021/acs.biochem.8b00140. Epub 2018 Mar 23. Biochemistry. 2018. PMID: 29553718 Free PMC article.
-
Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation.J Biol Chem. 2023 Aug;299(8):105012. doi: 10.1016/j.jbc.2023.105012. Epub 2023 Jul 4. J Biol Chem. 2023. PMID: 37414152 Free PMC article.
-
Mapping Post-Translational Modifications of de Novo Purine Biosynthetic Enzymes: Implications for Pathway Regulation.J Proteome Res. 2019 May 3;18(5):2078-2087. doi: 10.1021/acs.jproteome.8b00969. Epub 2019 Apr 18. J Proteome Res. 2019. PMID: 30964683 Free PMC article.
References
-
- Aoki T, Morris HP, Weber G (1982) Regulatory properties and behavior of activity of carbamoyl-phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues. J Biol Chem 257:432–438 - PubMed
-
- Boritzki TJ, Jackson RC, Morris HP, Weber G (1981) Guanosine 5′-phosphate synthetase and guanosine 5′-phosphate kinase in rat hepatomas and kidney tumors. Biochim Biophys Acta 658:102–110 - PubMed
-
- Denis C, Mayer D, Trocheris V, Viallard V, Paris H, Murat JC (1985) Study of carbohydrate metabolism in glycogen-storing cell lines derived from cultured rat hepatocytes. Int J Biochem 17:247–251 - PubMed
-
- Elliot WL, Weber G (1984) Proliferation-linked increase in phosphoribosyl-formylglycinamidine synthetase acticity (EC 6.3.5.3). Cancer Res 44:2430–2434 - PubMed
-
- Harkrader RJ, Jackson RC, Ross DA, Weber G (1980) Increase in liver and kidney deoxycytidine kinase activity linked to neoplastic transformation. Biochem Biophys Res Commun 96:1633–1639 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources